Us Bancorp \De\ Precision Biosciences Inc Transaction History

Us Bancorp \De\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.15 - $3.34 $3,067 - $8,907	-2,667 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$2.96 - $7.76 $2,705 - $7,092	-914 Reduced 25.52%	2,667 $8,000
Q4 2021 Feb 11, 2022	BUY	$7.4 - $11.66 $3,093 - $4,873	418 Added 13.22%	3,581 $26,000
Q3 2021 Nov 10, 2021	BUY	$9.18 - $14.15 $881 - $1,358	96 Added 3.13%	3,163 $37,000
Q2 2021 Aug 05, 2021	BUY	$8.07 - $12.52 $3,211 - $4,982	398 Added 14.91%	3,067 $38,000
Q4 2020 Feb 04, 2021	BUY	$5.98 - $12.47 $3,181 - $6,634	532 Added 24.89%	2,669 $22,000
Q3 2020 Nov 10, 2020	SELL	$4.65 - $8.73 $3,357 - $6,303	-722 Reduced 25.25%	2,137 $13,000
Q2 2020 Aug 07, 2020	SELL	$4.66 - $8.7 $9,925 - $18,531	-2,130 Reduced 42.69%	2,859 $24,000
Q1 2020 May 13, 2020	BUY	$5.05 - $15.01 $20,144 - $59,874	3,989 Added 398.9%	4,989 $30,000
Q4 2019 Feb 04, 2020	BUY	$6.32 - $19.66 $3,160 - $9,830	500 Added 100.0%	1,000 $14,000
Q3 2019 Nov 08, 2019	BUY	$8.03 - $14.82 $4,014 - $7,410	500 New	500 $4,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $531M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.